Purpurin Alleviates Chemotherapy‐Induced Thrombocytopenia Through Estrogen Receptor α Dependent Phosphoinositide 3‐Kinase/Protein Kinase B Signalling
Purpurin lindert chemotherapieinduzierte Thrombozytopenie über ein estrogenrezeptor-α-abhängiges Phosphoinositid-3-Kinase/Protein-Kinase-B-Signalweg
Phytotherapy Research · 29.10.2026
DOI: 10.1002/ptr.70469 ↗Auf einen Blick
Purpurin erhöhte in Zell-, Zebrafisch- und Mausmodellen die Megakaryopoese und die Thrombozytenzahl nach Cyclophosphamid-Exposition. Die Wirkung war mit ESR1-abhängiger PI3K/AKT-Signalisierung verknüpft.
Fragestellung
Ob Purpurin nach Cyclophosphamid-Exposition die Thrombozytenproduktion wiederherstellt und ob ESR1–PI3K/AKT beteiligt ist.
Methode
Untersuchung in K562- und Meg-01-Differenzierungsmodellen, Tg(itga2b:eGFP)-Zebrafischen und CTX-induzierten thrombopenischen Mäusen; zusätzlich DARTS und pharmakologische Hemmung von ESR1 und PI3K.
Ergebnisse
Bei 2,5–10 μM erhöhte Purpurin CD41+CD42b+-Zellen, MK-Ploidie, F-Aktin-Remodelling und die Expression von NF-E2, GATA1, RUNX1 und FOSB. In Zebrafischen stiegen Thrombozyten, in Mäusen erholten sich Thrombozytenzahl, MK-Reifung und Hämostase.
Schlussfolgerung der Autor:innen
Die Ergebnisse sprechen dafür, dass ESR1-assoziierte PI3K/AKT-Signalisierung die Purpurin-vermittelte Megakaryopoese und Thrombozytenerholung unterstützt. Purpurin soll weiter als natürlicher Kandidat für CIT geprüft werden.
Kernaussagen
- Purpurin wirkte in Zell-, Zebrafisch- und Mausmodellen.
- Erhöhte Megakaryozytenreifung und Thrombozytenzahlen.
- ESR1- und PI3K-Hemmung schwächte die Effekte ab.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 29.10.2026. Verfasst von Xiaolin Gan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Key Medical Laboratory of New Drug Discovery and Druggability, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Ch…. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Planning Project of Sichuan Province, China, Sichuan Provincial Central Government-Guided Local Scientific Research Project.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Chemotherapy‐induced thrombocytopenia (CIT) increases bleeding risk and compromises chemotherapy delivery. Purpurin, a hydroxyanthraquinone found in Rubia cordifolia L., has not been examined as a regulator of megakaryopoiesis. We investigated whether purpurin restores platelet production after cyclophosphamide (CTX) exposure and examined the involvement of estrogen receptor α (ESR1)–phosphoinositide 3‐kinase (PI3K)/protein kinase B (AKT) signalling. Purpurin was evaluated in K562 and Meg‐01 megakaryocytic differentiation models, Tg(itga2b:eGFP) zebrafish, and CTX‐induced thrombocytopenic mice. Megakaryocyte (MK) differentiation, DNA ploidy, cytoskeletal remodelling, platelet recovery, and haemostatic function were assessed. Computational target prediction was used for hypothesis generation, followed by drug affinity responsive target stability analysis and pharmacological inhibition of ESR1 and PI3K. At concentrations that did not cause detectable cytotoxicity (2.5–10 μM), purpurin increased CD41 + CD42b + cells, MK ploidy, F‐actin remodelling, and expression of NF‐E2, GATA1, RUNX1, and FOSB. Purpurin increased thrombocyte abundance in zebrafish and restored platelet counts, MK maturation, and haemostatic function in CTX‐treated mice. Purpurin increased the resistance of ESR1 to proteolysis in the drug affinity responsive target stability (DARTS) assay. Pharmacological inhibition of ESR1 or PI3K attenuated purpurin‐induced differentiation and PI3K/AKT phosphorylation. These findings support the involvement of ESR1‐associated PI3K/AKT signalling through which purpurin promotes megakaryopoiesis and platelet recovery. Purpurin warrants further evaluation as a natural‐product lead for CIT, including genetic target validation, pharmacokinetic characterization, and assessment in tumour‐bearing models.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sichuan Key Medical Laboratory of New Drug Discovery and Druggability, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, School of Pharmacy, Southwest Medical University…
- School of Basic Medical Sciences, Southwest Medical University, Luzhou, China.
- Department of Pharmacy, the Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
- Public Center of Experimental Technology, Southwest Medical University, Luzhou, China.
- Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, (Collaborative Innovation Center for Prevention of Cardiovascular Diseases), Institut…
ORCID-Profile: Xinle Wang, Xiang Xie, Xiang Li, Yan Li, Jianming Wu
Förderung
- National Natural Science Foundation of China
- Science and Technology Planning Project of Sichuan Province, China
- Sichuan Provincial Central Government-Guided Local Scientific Research Project
- Joint Project of Luzhou Municipal People's Government and Southwest Medical University
- Luzhou Science and Technology Program
Zitieren
APA
Gan, X., Wang, X., Hao, L., Tang, X., Liu, Z., Wang, L., Xie, X., Li, X., Zhao, C., Li, Y., Huang, X., Liu, Y., & Wu, J. (2026). Purpurin Alleviates Chemotherapy‐Induced Thrombocytopenia Through Estrogen Receptor α Dependent Phosphoinositide 3‐Kinase/Protein Kinase B Signalling. Phytotherapy Research. https://doi.org/10.1002/ptr.70469
Vancouver
Gan X, Wang X, Hao L, Tang X, Liu Z, Wang L, et al. Purpurin Alleviates Chemotherapy‐Induced Thrombocytopenia Through Estrogen Receptor α Dependent Phosphoinositide 3‐Kinase/Protein Kinase B Signalling. Phytotherapy Research. 2026. doi:10.1002/ptr.70469
BibTeX
@article{Gan2026,
author = {Gan, Xiaolin and Wang, Xinle and Hao, Lu and Tang, Xiaoqin and Liu, Zhixuan and Wang, Long and Xie, Xiang and Li, Xiang and Zhao, Chunling and Li, Yan and Huang, Xinwu and Liu, Yuanzhi and Wu, Jianming},
title = {Purpurin Alleviates Chemotherapy‐Induced Thrombocytopenia Through Estrogen Receptor α Dependent Phosphoinositide 3‐Kinase/Protein Kinase B Signalling},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70469}
}
EUVIMED